Skip to content
Dr. Grey AI

Protocol · Eye Health

Age-Related Macular Degeneration Protocol

AREDS2 Formula (Lutein, Zeaxanthin, Vitamin C, E, Zinc, Copper) is the core of this stack, with 4 supporting supplements. Each row gives the amount the protocol lists and the grade our evidence database holds for that supplement in Age-Related Macular Degeneration.

We are re-verifying the studies cited on protocol pages; only confirmed citations are shown.

The stack

5 supplements · 1 graded · 2 confirmed studies

Amount listed in this protocol; not a recommendation.

Supplements in the Age-Related Macular Degeneration protocol, with the amount the protocol lists, the grade on file and confirmed studies
GradeSupplementAmount listedWhy it’s in the stackEvidence on file
Primary stackThe core of this protocol
AREDS2 Formula (Lutein, Zeaxanthin, Vitamin C, E, Zinc, Copper)Amount listed: Standard AREDS2 formula daily

Evidence-based formula shown to reduce AMD progression by 25% in large clinical trials

Not graded yet

Confirmed studies for AREDS2 Formula (Lutein, Zeaxanthin, Vitamin C, E, Zinc, Copper) (titles as PubMed lists them)

Supporting stackListed as additions to the core
LuteinAmount listed: 10 mg daily (part of AREDS2)

Macular pigment that filters damaging blue light and provides antioxidant protection

Not graded yet
ZeaxanthinAmount listed: 2 mg daily (part of AREDS2)

Concentrated in central macula; works synergistically with lutein for blue light protection

Not graded yet
Omega-3 Fatty Acids (DHA)Amount listed: 1,000 mg DHA daily

DHA is concentrated in retinal photoreceptors; supports membrane fluidity and function

  • Cognitive Decline: improves
Not graded yet
SaffronAmount listed: 20–30 mg daily

Crocin and crocetin provide retinal antioxidant protection; may improve visual function

  • Macular Thickness: studied
  • Visual acuity (VA): improves
  • Retinal Function: improves
Grade D for Macular Thickness60 people

Confirmed studies for Saffron (titles as PubMed lists them)

How this protocol works

In plain language

Age-related macular degeneration (AMD) damages the central part of the retina responsible for sharp, detailed vision. Oxidative stress and blue light damage are key drivers. This protocol is based on major clinical trials.

  • AREDS2 formula is the only supplement proven in large trials to slow AMD progression. It reduced risk of advanced AMD by 25% over 5 years. The formula includes lutein (10mg), zeaxanthin (2mg), vitamin C (500mg), vitamin E (400 IU), zinc (80mg), and copper (2mg).
  • Lutein and zeaxanthin are carotenoid pigments that concentrate in the macula, forming "natural sunglasses" that filter harmful blue light. Higher macular pigment density is protective.
  • DHA (omega-3) is the primary structural fat in retinal photoreceptors. While the AREDS2 trial didn't show additional benefit, observational studies link high fish intake to lower AMD risk.
  • Saffron is an emerging supplement that has shown improved visual function in early AMD studies—possibly through antioxidant and anti-inflammatory effects.

Expected timeline: Macular pigment increases over 3-6 months of supplementation. Slowing progression requires long-term (years) of consistent use.

Note: AREDS2 is for intermediate/advanced AMD—discuss with your ophthalmologist.

Printed from drgrey.ai/protocols/macular-degeneration. For education only; not medical advice. Talk to a clinician before starting any supplement.